WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) announced today that senior officials will be available by phone tomorrow to discuss follow-on biologics. The Senate Committee on Health, Education, Labor, and Pensions is scheduled to explore the issue of follow-on biologics in a hearing tomorrow morning.
